Man Group’s Astera Labs ALAB Stock Holding History

Man Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.63M	Buy	15,800 +15,300	+3,060%	+$4.06M	0.01%	918
2026 Q1	$54.8K	Buy	+500	New	+$71.2K	﹤0.01%	2363

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Man Group's ALAB Position: Q2 2026 in Review

Man Group increased its Astera Labs (ALAB) stake by 171% in Q2 2026, buying an estimated $15.9M and bringing the position to 95,224 shares worth $46M. The position accounts for 0.07% of the portfolio, ranked #270.

Man Group first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Man Group held 95,224 shares of Astera Labs worth $46M as of Q2 2026.
Man Group bought 60,036 Astera Labs shares in Q2 2026, an estimated $15.9M.
Astera Labs made up 0.07% of Man Group's portfolio in Q2 2026, its #270 holding.
Man Group first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.